These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 17707275)
1. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation. Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861 [TBL] [Abstract][Full Text] [Related]
3. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells. Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509 [TBL] [Abstract][Full Text] [Related]
5. HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. Wang CC; Liao YP; Mischel PS; Iwamoto KS; Cacalano NA; McBride WH Cancer Res; 2006 Jul; 66(13):6756-62. PubMed ID: 16818651 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Chung YL; Lee MY; Pui NN Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790 [TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells. Jin H; Liang L; Liu L; Deng W; Liu J J Cell Biochem; 2013 Jul; 114(7):1498-509. PubMed ID: 23297003 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate. Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311 [TBL] [Abstract][Full Text] [Related]
9. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. De Schutter H; Kimpe M; Isebaert S; Nuyts S Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824 [TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409 [TBL] [Abstract][Full Text] [Related]
11. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant]. Tsuchiya K Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406 [TBL] [Abstract][Full Text] [Related]
12. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines. Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. McIlwrath AJ; Vasey PA; Ross GM; Brown R Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090 [TBL] [Abstract][Full Text] [Related]
14. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Li XN; Parikh S; Shu Q; Jung HL; Chow CW; Perlaky L; Leung HC; Su J; Blaney S; Lau CC Clin Cancer Res; 2004 Feb; 10(3):1150-9. PubMed ID: 14871995 [TBL] [Abstract][Full Text] [Related]
15. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line. Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status. Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Zhang AL; Russell PJ; Knittel T; Milross C Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933 [TBL] [Abstract][Full Text] [Related]